CANL (CANL)
Tests cannabis products for safety, potency, and quality.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
CANL is trading at its 52-week low with minimal movement today. The stock sits above both its 50- and 200-day moving averages, suggesting some near-term technical support. Overall sentiment appears neutral, with analyst coverage likely thin at this price level.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—